Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

OBJECTIVES: To assess whether combination therapy with infliximab (IFX) plus nonsteroidal anti-inflammatory drugs (NSAIDs) is superior to NSAID monotherapy for reaching Assessment of SpondyloArthritis international Society (ASAS) partial remission in patients with early, active axial spondyloarthrit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieper, J, Lenaerts, J, Wollenhaupt, J, Rudwaleit, M, Mazurov, V I, Myasoutova, L, Park, S, Song, Y, Yao, R, Chitkara, D, Vastesaeger, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888606/
https://www.ncbi.nlm.nih.gov/pubmed/23696633
http://dx.doi.org/10.1136/annrheumdis-2012-203201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888606/
https://www.ncbi.nlm.nih.gov/pubmed/23696633
http://dx.doi.org/10.1136/annrheumdis-2012-203201

Ejemplares similares